Modelling the economic burden of SARS-CoV-2 infection in health care workers in four countries.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
16 05 2023
16 05 2023
Historique:
received:
08
12
2022
accepted:
03
05
2023
medline:
17
5
2023
pubmed:
16
5
2023
entrez:
15
5
2023
Statut:
epublish
Résumé
Health care workers (HCWs) experienced greater risk of SARS-CoV-2 infection during the COVID-19 pandemic. This study applies a cost-of-illness (COI) approach to model the economic burden associated with SARS-CoV-2 infections among HCWs in five low- and middle-income sites (Kenya, Eswatini, Colombia, KwaZulu-Natal province, and Western Cape province of South Africa) during the first year of the pandemic. We find that not only did HCWs have a higher incidence of COVID-19 than the general population, but in all sites except Colombia, viral transmission from infected HCWs to close contacts resulted in substantial secondary SARS-CoV-2 infection and death. Disruption in health services as a result of HCW illness affected maternal and child deaths dramatically. Total economic losses attributable to SARS-CoV-2 infection among HCWs as a share of total health expenditure ranged from 1.51% in Colombia to 8.38% in Western Cape province, South Africa. This economic burden to society highlights the importance of adequate infection prevention and control measures to minimize the risk of SARS-CoV-2 infection in HCWs.
Identifiants
pubmed: 37188709
doi: 10.1038/s41467-023-38477-7
pii: 10.1038/s41467-023-38477-7
pmc: PMC10185455
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2791Informations de copyright
© 2023. The Author(s).
Références
J Infect Dis. 2018 Nov 22;218(suppl_5):S698-S704
pubmed: 30321368
Health Policy Plan. 2021 Aug 12;36(7):1140-1151
pubmed: 34146394
Lancet Glob Health. 2021 Jun;9(6):e759-e772
pubmed: 33811827
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
EClinicalMedicine. 2020 Aug;25:100471
pubmed: 32840491
Pan Afr Med J. 2021 Dec 21;40:254
pubmed: 35251448
Eur J Health Econ. 2022 Mar;23(2):249-259
pubmed: 34417904
J Infect Public Health. 2021 Sep;14(9):1174-1178
pubmed: 34392070
BMJ Glob Health. 2022 Jan;7(1):
pubmed: 35012970
Lancet Infect Dis. 2016 Aug;16(8):935-41
pubmed: 27091092
BMJ. 2020 Oct 28;371:m3582
pubmed: 33115726
Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):241-247
pubmed: 32342698
Int J Infect Dis. 2021 Mar;104:335-346
pubmed: 33444754
Emerg Infect Dis. 2020 Jun;26(6):1059-1066
pubmed: 32187007
Lancet. 2004 Oct 30-Nov 5;364(9445):1603-9
pubmed: 15519630
Lancet. 2016 Sep 24;388(10051):1311-24
pubmed: 27475266
JAMA. 2020 Apr 21;323(15):1439-1440
pubmed: 32163102
Lancet. 2020 Sep 5;396(10252):e24
pubmed: 32861312
Lancet Diabetes Endocrinol. 2017 Jun;5(6):423-430
pubmed: 28456416
Int J Infect Dis. 2021 Feb;103:525-526
pubmed: 33333249
BMJ Glob Health. 2020 Jan 7;5(1):e001535
pubmed: 32133161
Nat Med. 2021 Jun;27(6):964-980
pubmed: 34002090
J Hosp Infect. 2021 Aug;114:126-133
pubmed: 33894306
Clin Mol Hepatol. 2014 Dec;20(4):327-37
pubmed: 25548737
J Cancer Policy. 2022 Mar;31:100316
pubmed: 35559868
Pathog Glob Health. 2015 Feb;109(1):4-9
pubmed: 25578284
BMC Health Serv Res. 2021 Oct 28;21(1):1169
pubmed: 34711242
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
N Engl J Med. 2020 Aug 6;383(6):513-515
pubmed: 32402153
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512